Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

Medicare is big business, recently providing healthcare coverage to 68 million people. Before the 2024 election, fully 94% of ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

January, the Biden administration released its proposed Medicare Advantage rates in 2026. These are the rates that the ...

The Inflation Reduction Act of 2022 has triggered a raft of changes to Medicare Part D plans and Medicare Advantage plans that affect prescription drug coverage in 2025. Here’s what to know.

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...

Millions in Wisconsin have prescription drug coverage through Medicare Part D or the Medicare Advantage plan, according to ...

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...